TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422G957. A total of 1 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,312 | -72.0% | 14,800 | -51.9% | 0.00% | -100.0% |
| Q2 2023 | $473,088 | +73.8% | 30,800 | +154.5% | 0.00% | +100.0% |
| Q1 2023 | $272,129 | +3787.6% | 12,100 | +3933.3% | 0.00% | – |
| Q2 2022 | $7,000 | +133.3% | 300 | +200.0% | 0.00% | – |
| Q1 2022 | $3,000 | -99.2% | 100 | -99.2% | 0.00% | – |
| Q4 2021 | $391,000 | +59.6% | 12,600 | +24.8% | 0.00% | – |
| Q3 2021 | $245,000 | +2622.2% | 10,100 | +1583.3% | 0.00% | – |
| Q2 2021 | $9,000 | -10.0% | 600 | +50.0% | 0.00% | – |
| Q1 2021 | $10,000 | +233.3% | 400 | +300.0% | 0.00% | – |
| Q4 2020 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |